Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
East Melbourne, Victoria-based Cerulea Clinical Trials operates in Biotechnology Research. It is a nonprofit, and its site is ceruleaclinicaltrials.org.au. It holds one address on record, all in Australia. Headcount on record is 16. Its work is tagged medical devices, medical research and ophthalmology. It is listed alongside eight similar brands, mostly in Research Services.
ceruleaclinicaltrials.org.au LinkedIn
Cerulea Clinical Trials delivers ophthalmic clinical trials for Australian and international biopharmaceutical and medtech companies – and is the home of investigator-initiated studies for the Centre for Eye Research Australia (CERA).
We are a fully owned, not-for-profit subsidiary of CERA and share its vision of a world free from vision loss and blindness.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
16 counted staff profiles at January 2026, inside the self-reported 11–50 band.
One address on record, Australia only. Primary: 32 Gisborne St, Level 7, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria 3002.
None linked to this brand.
Nine tags on the brand's own list, among them medical devices, medical research and ophthalmology.
12 profiles list Cerulea Clinical Trials as a peer — 85th percentile in Biotechnology Research. It lists ten peers of its own. Alithia Life Sciences and Kinoxis Therapeutics Pty Ltd list it back.